QMS Medical Allied Services (NSE:QMSMEDI) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QMSMEDI QMS Medical Allied Services Ltd NSE:QMSMEDI
76 GF Score
Price ₹151.89
GF Value ₹129.99
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is QMS Medical Allied Services Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of QMS Medical Allied Services is: Moderate Risk: Sensitive, better choose undervalued stock.

QMS Medical Allied Services  (NSE:QMSMEDI) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

QMS Medical Allied Services Risk Assessment Related Terms

NSE:QMSMEDI vs ISRG, BDX, MDLN: Risk Assessment Comparison

For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QMS Medical Allied Services Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's Risk Assessment distribution charts can be found below:

* The bar in red indicates where QMS Medical Allied Services's Risk Assessment falls into.


NSE:QMSMEDI
76GF Score
QMS Medical Allied Services Ltd NSE:QMSMEDI
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?

Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be overvalued. The current stock price of ₹151.89 is trading 16.8% above its estimated GF Value™ of ₹129.99. GuruFocus considers QMS Medical Allied Services to be Modestly Overvalued.

Key valuation signals for NSE:QMSMEDI:

  • Risk Assessment:
  • GF Value™: ₹129.99 vs. price of ₹151.89 (16.8% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QMS Medical Allied Services Business Description

Address Prabhat Colony, Road No. 3, 1A-B/2A-B, Navkala Bharti Building, Plot No. 16, Near Santacruz Bus Depot, Santacruz (East), Mumbai, MH, IND, 400055
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
76GF Score

Get the complete analysis for NSE:QMSMEDI

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹151.89
Price
₹129.99
GF Value